1. Home
  2. DFH vs SDGR Comparison

DFH vs SDGR Comparison

Compare DFH & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dream Finders Homes Inc.

DFH

Dream Finders Homes Inc.

HOLD

Current Price

$15.22

Market Cap

1.2B

ML Signal

HOLD

SDGR

Schrodinger Inc.

HOLD

Current Price

$18.01

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFH
SDGR
Founded
2008
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
DFH
SDGR
Price
$15.22
$18.01
Analyst Decision
Hold
Buy
Analyst Count
2
9
Target Price
$26.00
$21.00
AVG Volume (30 Days)
651.4K
1.1M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
0.37
N/A
Revenue
$4,322,848,000.00
$255,869,000.00
Revenue This Year
$0.81
$0.76
Revenue Next Year
$7.82
$4.60
P/E Ratio
$40.11
N/A
Revenue Growth
N/A
23.29
52 Week Low
$12.20
$10.95
52 Week High
$31.10
$23.02

Technical Indicators

Market Signals
Indicator
DFH
SDGR
Relative Strength Index (RSI) N/A 70.19
Support Level N/A $17.26
Resistance Level N/A $19.51
Average True Range (ATR) 0.00 0.72
MACD 0.00 0.28
Stochastic Oscillator 0.00 80.55

Price Performance

Historical Comparison
DFH
SDGR

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc designs, builds and sells homes in markets throughout the United States. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the maximum of its revenue from the Midwest segment.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: